Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 43Gastrointestinal 33Other hematologic neoplasm 28Thoracic 21Genitourinary 15Plasma cell 14Gynecologic 14Myeloid 13CNS 13Sarcoma 12Head & Neck 12Endocrine 9Dermatologic 9NET 7Other neoplasm 6Breast 4Tumor-Agnostic 2Other solid neoplasm 1Classical hematology 1

Conditions

Neoplasms 3802Neoplasm Metastasis 763Carcinoma 125Adenocarcinoma 116Carcinoma, Squamous Cell 98Neoplasms, Unknown Primary 38Neoplasm, Residual 30Neoplasms, Second Primary 27Neoplasms by Site 4Neoplasms by Histologic Type 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms by Histologic Type × Tumor-Agnostic × Clear all
NCT06175780 2023-12-26

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Phase 1 Unknown
189 enrolled
Tumor-Agnostic

Neoplasms, Neoplasms by Histologic Type

NCT03109639 2020-03-19

A Randomized Prospective Comparison of the New EUS Guided Acquire TM Needle Biopsy vs EUS Guided Fine Needle Aspiration for Suspected Solid Gastrointestinal Lesions

Singapore General Hospital

Phase NA Completed
36 enrolled
Tumor-Agnostic

Neoplasms by Histologic Type

Data powered by HemOnc (CC BY 4.0) Colophon âš¡